Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Arce Garcia-Jaraquemada"'
Autor:
Roger Suau, Anna Garcia, Carla Bernal, Mariona Llaves, Katharina Schiering, Eva Jou-Ollé, Alex Pertegaz, Arce Garcia-Jaraquemada, Ramon Bartolí, Violeta Lorén, Patri Vergara, Míriam Mañosa, Eugeni Domènech, Josep Manyé
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6424 (2023)
The lack of knowledge regarding the pathogenesis of IBD is a challenge for the development of more effective and safer therapies. Although in vivo preclinical approaches are critical for drug testing, none of the existing models accurately reproduce
Externí odkaz:
https://doaj.org/article/7addf52702be4b6db7ddfc11c657bf87
Autor:
Antonio Julià, Adrià Aterido, Yamile Zabana, Juan Jose Lozano, Elisabet Pedrosa, Maria Rosa Sarrias, Violeta Lorén, Eduard Cabré, Arce Garcia-Jaraquemada, María Vicario, Míriam Mañosa, J. Manyé, Eugeni Domènech, José Troya, Miriam Ferreiro
Publikováno v:
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Crohn's disease (CD) is a complex and multifactorial illness. There are still considerable gaps in our knowledge regarding its pathophysiology. A transcriptomic approach could shed some light on little-known biological alterations of the disease. We
Autor:
Eduard Cabré, Isabel Ojanguren, Violeta Lorén, Eugeni Domènech, Elisabet Pedrosa, Míriam Mañosa, Arce Garcia-Jaraquemada, J. Manyé
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 6, p e0130921 (2015)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS ONE, Vol 10, Iss 6, p e0130921 (2015)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Altres ajuts: 2012 Spanish Gastroenterological Association i CIBER G0034 Glucocorticosteroids are the first line therapy for moderate-severe flare-ups of ulcerative colitis. Despite that, up to 60% of patients do not respond adequately to steroid tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eeee12927e4aa550bfeb4f3233b1b07
https://ddd.uab.cat/record/163053
https://ddd.uab.cat/record/163053
Autor:
Eugeni Domènech, Violeta Lorén, Míriam Mañosa, Arce Garcia-Jaraquemada, Eduard Cabré, Belén Beltrán, Inés Moret, Josep Mañé, Guillermo Bastida, Juan E. Naves
Publikováno v:
Gastroenterology. 146:S-875
Autor:
Violeta Lorén, Eduard Cabré, Isabel Ojanguren, Eugeni Domènech, Elisabet Pedrosa, Arce García-Jaraquemada, Miriam Mañosa, Josep Manyé
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0130921 (2015)
Glucocorticosteroids are the first line therapy for moderate-severe flare-ups of ulcerative colitis. Despite that, up to 60% of patients do not respond adequately to steroid treatment. Previously, we reported that low IL-10 mRNA levels in intestine a
Externí odkaz:
https://doaj.org/article/990ad43cbf6e418da0dc1e14ce1a9cac